Regen BioPharma (Regen BioPharma) Effective Interest Rate on Debt % : 11.93% (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Regen BioPharma Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Regen BioPharma's annualized positive value of Interest Expense for the quarter that ended in Mar. 2024 was $0.08 Mil. Regen BioPharma's average total debt for the quarter that ended in Mar. 2024 was $0.70 Mil. Therefore, Regen BioPharma's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2024 was 11.93%.

Regen BioPharma Effective Interest Rate on Debt % Historical Data

The historical data trend for Regen BioPharma's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regen BioPharma Effective Interest Rate on Debt % Chart

Regen BioPharma Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Effective Interest Rate on Debt %

Get a 7-Day Free Trial

95.11

39.69

11.86

8.65

5.81

Regen BioPharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Effective Interest Rate on Debt %	Get a 7-Day Free Trial															-	9.15	9.35	11.96	11.93

Competitive Comparison of Regen BioPharma's Effective Interest Rate on Debt %

For the Biotechnology subindustry, Regen BioPharma's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regen BioPharma's Effective Interest Rate on Debt % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Regen BioPharma's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Regen BioPharma's Effective Interest Rate on Debt % falls into.

Regen BioPharma Effective Interest Rate on Debt % Calculation

Regen BioPharma's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Sep. 2023 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (A: Sep. 2022 )	+	Total Debt (A: Sep. 2023 ))	/ count )
=	-1 * -0.059	/	( (1.274	+	0.757)	/ 2 )
=	-1 * -0.059	/	1.0155
=	5.81 %

where

	Total Debt (A: Sep. 2022 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0	+	1.274
=	1.274

	Total Debt (A: Sep. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0.15	+	0.607
=	0.757

Regen BioPharma's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2024 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (Q: Dec. 2023 )	+	Total Debt (Q: Mar. 2024 ))	/ count )
=	-1 * -0.084	/	( (0.714	+	0.694)	/ 2 )
=	-1 * -0.084	/	0.704
=	11.93 %

where

	Total Debt (Q: Dec. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0.154	+	0.56
=	0.714

	Total Debt (Q: Mar. 2024 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0.144	+	0.55
=	0.694

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Mar. 2024) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

Regen BioPharma (OTCPK:RGBP) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

Regen BioPharma Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Regen BioPharma's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.

Regen BioPharma (Regen BioPharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regen BioPharma Inc (OTCPK:RGBP) » Definitions » Effective Interest Rate on Debt %

Comparable Companies

Traded in Other Exchanges

RGBPP.PFD:USA

Address

4700 Spring Street, Suite 304, La Mesa, CA, USA, 91942

Website

https://www.regenbiopharmainc.com

Regen BioPharma Inc is a US-based biotechnology company. It focuses on the development of regenerative medical applications in the stem cell space. The company's principal products and services include HemaXellarate I, HemaXellerate II, dCell Vax, NR2F6, Tcellvax, identification of Small Molecules, and others. HemaXellarate I and HemaXellerate II is a cellular therapy designed to heal damaged bone marrow. dCell Vax is a therapy whereby dendritic cells of the cancer patient are harvested from the body. Tcellvax is an autologous cellular product comprised of NR2F6 gene-silenced peripheral blood mononuclear cells.